Language-agnostic pharmacovigilant text mining to elicit side effects from clinical notes and hospital medication records.

Journal: Basic & clinical pharmacology & toxicology
Published Date:

Abstract

We sought to craft a drug safety signalling pipeline associating latent information in clinical free text with exposures to single drugs and drug pairs. Data arose from 12 secondary and tertiary public hospitals in two Danish regions, comprising approximately half the Danish population. Notes were operationalised with a fastText embedding, based on which we trained 10 270 neural-network models (one for each distinct single-drug/drug-pair exposure) predicting the risk of exposure given an embedding vector. We included 2 905 251 admissions between May 2008 and June 2016, with 13 740 564 distinct drug prescriptions; the median number of prescriptions was 5 (IQR: 3-9) and in 1 184 340 (41%) admissions patients used ≥5 drugs concomitantly. A total of 10 788 259 clinical notes were included, with 179 441 739 tokens retained after pruning. Of 345 single-drug signals reviewed, 28 (8.1%) represented possibly undescribed relationships; 186 (54%) signals were clinically meaningful. Sixteen (14%) of the 115 drug-pair signals were possible interactions, and two (1.7%) were known. In conclusion, we built a language-agnostic pipeline for mining associations between free-text information and medication exposure without manual curation, predicting not the likely outcome of a range of exposures but also the likely exposures for outcomes of interest. Our approach may help overcome limitations of text mining methods relying on curated data in English and can help leverage non-English free text for pharmacovigilance.

Authors

  • Benjamin Skov Kaas-Hansen
    Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.
  • Davide Placido
    NNF Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
  • Cristina Leal Rodríguez
    NNF Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
  • Hans-Christian Thorsen-Meyer
    Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Simona Gentile
    Department of Radiology, Zealand University Hospital, Roskilde, Denmark.
  • Anna Pors Nielsen
    NNF Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
  • Søren Brunak
    NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
  • Gesche Jürgens
    Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.
  • Stig Ejdrup Andersen
    Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.